Evidence map›Paper›PMID 31555755›Full record

ArticleJournal of the Endocrine Society2019

Higher C-Peptide Level During Glucose Clamp Is Associated With Muscle Insulin Resistance in Nonobese Japanese Men.

Hideyoshi Kaga, Yoshifumi Tamura, Kageumi Takeno, Saori Kakehi, Yuki Someya, Takashi Funayama, Yasuhiko Furukawa, Ruriko Suzuki, Daisuke Sugimoto, Satoshi Kadowaki and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Hideyoshi KagaDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoshifumi TamuraDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0003-0943-0712
Kageumi TakenoDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Saori KakehiDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yuki SomeyaSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takashi FunayamaDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yasuhiko FurukawaDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ruriko SuzukiDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Daisuke SugimotoDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Satoshi KadowakiDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Miho Nishitani-YokoyamaDepartment of Cardiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kazunori ShimadaSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiroyuki DaidaSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shigeki AokiSportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Adria GiaccaDepartments of Physiology and Medicine, Institute of Medical Science and Banting and Best Diabetes Centre, University of Toronto, Toronto, Canada.
Akio KanazawaDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ryuzo KawamoriDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hirotaka WatadaDepartment of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Juntendo University · JPUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextCirculating C-peptide is generally suppressed by exogenous insulin infusion. However, steady-state serum C-peptide (SS

objectiveTo investigate the clinical parameters associated with interindividual variations in SS DESIGN AND

participantsWe studied 49 nonobese (BMI < 25 kg/m

resultsWe divided subjects into high and low SS

conclusionsIn healthy, nonobese men, higher SS

Indexed as

feedback inhibition of insulin secretionhyperinsulinemiainsulin resistancenonobese

Identifiers

PMID31555755
PMCPMC6753586
OpenAlexW2964696860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.